New stomach bug treatment shows promise in head-to-head trial
NCT ID NCT06340334
First seen Mar 05, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study tested two different drug combinations to treat Helicobacter pylori, a bacteria that can cause stomach ulcers and other issues. About 400 adults took either a two-drug therapy (tegoprazan and amoxicillin) or a four-drug therapy (including bismuth and furazolidone). The goal was to see which treatment works better and has fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nanjing First Hospital
Nanjing, China
Conditions
Explore the condition pages connected to this study.